New targeted drug shows promise for Hard-to-Treat lung cancer
NCT ID NCT01625234
First seen Apr 30, 2026 · Last updated Apr 30, 2026
Summary
This study tested a new drug called ensartinib (X-396) in 131 people with advanced solid tumors, including those with ALK-positive non-small cell lung cancer. The main goal was to find the safest dose and see if the drug could shrink tumors. Results helped guide further research on this targeted therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope National Med Ctr
Duarte, California, 91010, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
New York University Langone Medical Center
New York, New York, 10016, United States
-
Providence Portland Medical Center
Portland, Oregon, 97213, United States
-
Stanford University
Stanford, California, 94305, United States
-
Tennessee Oncology, PLLC
Nashville, Tennessee, 37203, United States
-
UCSD Moores Cancer Center
La Jolla, California, 92093, United States
-
University of Southern California Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Wisconsin Carbone Cancer Ctr
Madison, Wisconsin, 53792, United States
-
Vanderbilt University
Nashville, Tennessee, 37240, United States
-
Walter Reed National Military Medical Center
Bethesda, Maryland, 20889, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.